If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Annamaria Catino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Mitoxantrone Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

Fluorescence In Situ Hybridization
Non-Small Cell Lung Carcinoma
Immunohistochemistry
anaplastic lymphoma kinase
Gene Amplification

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Jan 1 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Confidence Intervals

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., DE Marinis, F., Sperandi, F., Piantedosi, F., Vitali, M., Parra, H. J. S., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Aug 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Confidence Intervals

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

Cancer), I. A. FONICAP. O. N. I. F. A. L., Santo, A., Pilotto, S., Galetta, D., Grossi, F., Fasola, G., Romano, G., Bonanno, L., Bearz, A., Papi, M., Roca, E., Catino, A., Follador, A., Rijavec, E., Genova, C., Petrillo, P., Favaretto, A., Giannone, L., Milella, M., Tortora, G. & 2 others, Giannarelli, D. & Bria, E., Aug 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Maintenance
Disease-Free Survival
Observation
Random Allocation

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

On behalf of the Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer), Aug 1 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Maintenance
Disease-Free Survival
Observation
Survival